Evangelos Terpos, Efstathios Kastritis, Sosana Delimpasi, Maria Papathanasiou, Vasiliki Lampropoulou, Nikolaos Kanellias, Ioannis Ntanasis-Stathopoulos, Magdalini Migkou, Foteini Theodorakakou, Vasiliki Spiliopoulou, Evangelos Eleutherakis-Papaiakovou, Yagnik Vyas, Maria Kotsopoulou, Eirini Katodrytou, Maria Gavriatopoulou, Meletios Dimopoulos. "Isatuximab with bortezomib, cyclophosphamide, and dexamethasone followed by isatuximab and lenalidomide maintenance in newly diagnosed multiple myeloma patients with severe renal impairment: Final analysis of a phase 2 study by the greek myeloma study group." Blood, 2025. doi:10.1182/blood-2025-4036